Mitchell R. Butier
Analyst · Robert W
Thanks, Dean. As you can see, we had a solid year, with adjusted earnings per share growth of 20%, reflecting strong performance in Pressure-sensitive Materials, solid progress in RBIS, the early results of our restructuring program and accretion from share repurchases. For the year, we delivered organic sales growth of 4%, adjusted EPS of $2.08 and free cash flow from continuing operations of $312 million, all in line with our long-term targets and at the upper end of the guidance that we set at the beginning of the year. With leverage in our targeted range and with our consistently strong free cash flow, we continue to deliver on our commitment to return cash to shareholders. In fact, we returned nearly all of our free cash flow to shareholders in 2012, through both dividends and the repurchase of 7.9 million shares, or as Dean mentioned, about 7% of our outstanding shares. In the fourth quarter, we delivered strong results with adjusted EPS of $0.54 and organic sales growth of approximately 7%. Sales came in stronger than expected with the vast majority of the quarter's growth coming in November and December. A shift in the timing of our fiscal year end also added about 1 point of growth in the quarter. Adjusted operating margin in the quarter grew 170 basis points, as the benefit of higher volume and productivity initiatives more than offset higher employee-related expenses and the impact of changes in product mix, specifically in PSM. The net impact of raw material input cost and pricing continued to be neutral in the quarter. Now we've been talking about our cost-reduction program that will structurally reduce our overhead costs and save more than $100 million annually. We're on track and continue to expect to achieve our savings target by the middle of this year. These actions will increase our ability to deliver our targeted earnings growth regardless of market conditions. The actions we've taken, which include consolidation of operations and streamlining of the corporate center, are reflected in the adjustments we've made to segment and corporate expense reporting. Operating executives are now directly accountable for externally-reported segment results, while gaining greater control over certain functional costs that had been previously controlled from the center. The net effect from a reporting perspective is higher corporate expense, offset by a corresponding reduction in costs allocated to the segments. Note that this adjustment in allocation methodology has been reflected by an increase in our long-term segment margin targets. Turning to the segments. Pressure-sensitive Materials sales were up 6% on an organic basis in the fourth quarter, primarily reflecting solid growth in North America and emerging markets. Label and Packaging Materials sales grew mid-single digits, with mid-single-digit growth in North America, low single-digit growth in Western Europe and low double-digit growth in emerging markets. Combined sales for other product lines, that is Graphics, Reflective and Performance Tapes, were up mid-single digits. PSM's adjusted operating margin improved 100 basis points to 8.7% (sic) [7.8%] as the benefit of higher volume and productivity initiatives more than offset the impact of product mix and higher employee-related expenses. Retail Branding and Information Solutions sales grew 10% with about 1/2 of the growth coming from RFID and the remainder being driven primarily by strong growth at North American retailers and brands. Overall, we believe we continue to gain share in both the U.S. and Europe. Sales of RFID products more than doubled in the fourth quarter and grew about 60% for the full year, a pace that is expected to moderate somewhat as a major retailer recently decided to slow the pace of their RFID adoption. RBIS' adjusted operating margin improved 270 basis points to 6.2%, as the benefit of higher volume and productivity initiatives more than offset higher employee-related expenses. Sales in our other specialty converting businesses grew 15%, with DES being the primary driver. And adjusted operating margin improved by more than 12 points to 6.4%, due primarily to the higher volume. In May of last year, we established long-term targets for the company and the operating segments, as shown on Slides 12 and 13. These targets represent a balance of aspiration and pragmatism, and we are committed to delivering them. As I said earlier, we achieved the targets for the company in 2012. Moving onto the outlook for 2013. We expect adjusted 2013 earnings per share from continuing operations of $2.40 to $2.80 and free cash flow from continuing operations of $275 million to $325 million. This guidance is based on a number of assumptions, including the key listed factors. To comment on a few. Our estimate for organic sales growth in 2013 is 1% to 4%. This reflects our business in the U.S. being flat to up 2%; Western Europe, flat to down 2%; and emerging markets, up 5% to 7%. Obviously, the macro environment remains uncertain and we continue to have limited forward visibility. Based on recent exchange rates, currency translation is expected to have a modest benefit to reported sales growth and EBIT. We expect to realize an incremental pretax benefit of approximately $70 million from our restructuring program. The minimum pension requirement for 2013 is $60 million. In addition to the required minimum, we anticipate using a portion of the net proceeds from the sale of OCP and DES to make an additional pension contribution. Any such additional pension contribution is excluded from our definition of free cash flow, and therefore, not reflected in our guidance. Average fully diluted shares outstanding for 2013 are assumed to be approximately $100 million. And it is important to note that our guidance includes the anticipated operating results of DES in continuing operations and excludes the effect on the share count of any share repurchases made with the net proceeds from the divestitures. So in summary, the fourth quarter represented a strong finish to a solid year in which we delivered full year organic growth of 4% and adjusted EPS growth of 20%. With the sale of OCP and DES, we've increased the focus of the company. Our 2 core businesses are market leaders and are well positioned for profitable growth and increasing returns. Our cost reduction program to save more than $100 million is on track and positions us for strong earnings growth in 2013. And our continued cost and capital discipline enable us to maintain our financial strength and return more cash to shareholders, all of which demonstrate our commitment to delivering on our long-term targets, including our expectation of adjusted EPS growth of 15% to 35% in 2013. I would be happy to take your questions.